Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Denmark
  4. Nasdaq Copenhagen
  5. Novo Nordisk A/S
  6. News
  7. All News
    NOVO B   DK0060534915

NOVO NORDISK A/S

(NOVO B)
  Report
Real-time Estimate Quote. Real-time Estimate Cboe Europe - 01/27 07:22:32 am
623.65 DKK   +0.88%
01/26NOVO NORDISK : JP Morgan remains Neutral
MD
01/26NOVO NORDISK : Goldman Sachs remains its Buy rating
MD
01/25Liberum Capital Downgrades Novo Nordisk to Sell from Hold
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
All news about NOVO NORDISK A/S
01/26NOVO NORDISK : JP Morgan remains Neutral
MD
01/26NOVO NORDISK : Goldman Sachs remains its Buy rating
MD
01/25Liberum Capital Downgrades Novo Nordisk to Sell from Hold
MT
01/25NOVO NORDISK : Gets a Neutral rating from JP Morgan
MD
01/24Novo Nordisk A/S – Share repurchase programme
AQ
01/24NOVO NORDISK : Gets a Buy rating from Bernstein
MD
01/21Novo Nordisk Repurchases 4 Million B Shares Under Stock Buyback Plan
MT
01/20Arecor Therapeutics Initiates Early-Stage Clinical Trial for Insulin Formation
MT
01/14Novo Nordisk Settles Securities Case in Denmark
MT
01/14Novo Nordisk announces settlement of securities lawsuit in Denmark
AQ
01/10Novo Nordisk A/S – Share repurchase programme
AQ
01/062Seventy Bio Working With Novo Nordisk to Develop Potential Gene-Editing Treatment for ..
MT
01/062seventy bio, Inc. Announces Expanded Collaboration Agreement with Novo Nordisk to Cont..
CI
01/06NOVO NORDISK : Deutsche Bank remains Neutral
MD
01/06NOVO NORDISK : Receives a Sell rating from Jefferies
MD
01/05Humanwell Healthcare to Sell Entire RiteDose Stake For $174 Million; Shares Jump 3%
MT
01/04NOVO NORDISK : Gets a Neutral rating from JP Morgan
MD
01/04NOVO NORDISK : Bernstein reiterates its Buy rating
MD
01/03European ADRs Move Higher in Monday Trading
MT
01/03NOVO BUYING PRIVATELY-OWNED MEDICAL : Bloomberg
MT
2021Dicerna Pharmaceuticals Coverage Dropped by Chardan After Novo Nordisk Closes Acquisiti..
MT
2021Chardan Drops Coverage on Neutral-Rated Dicerna Pharmaceuticals on Acquisition by Novo ..
MT
2021Tech, healthcare stocks lead European shares lower as Omicron cases swell
RE
2021Novo Nordisk Completes Dicerna Pharmaceuticals Acquisition
MT
2021Novo Nordisk Closes on $3.3 Billion Acquisition of Dicerna Pharmaceuticals
MT
2021NOVO NORDISK A/S (CPSE : NOVO B) completed the acquisition of remaining 97% stake in Dicer..
CI
2021NOVO NORDISK : Kepler Cheuvreux gives a Neutral rating
MD
2021NOVO NORDISK : Receives a Buy rating from Barclays
MD
2021European Stocks End Lower as Countries Tighten Rules In Wake of Surging COVID-19 Cases
MT
2021JPMorgan Downgrades Novo Nordisk to Neutral From Overweight
MT
2021Novo Nordisk Announces That A Contract Manufacturer Filling Syringes for Wegovy Pens fo..
CI
2021Novo Nordisk Slumps 11% Amid Expected H1 2022 Shortage for Weight Management Medication
MT
2021Novo Nordisk Shares Tumble on Supply Challenges for Obesity Drug Wegovy
DJ
2021European stocks drop as Omicron worries intensify
RE
2021Novo Nordisk shares tank after key drug hope hit by U.S. supply issues
RE
2021NOVO NORDISK : JP Morgan is Neutral
MD
2021Novo Nordisk Flags H1 2022 Shortage for Weight Management Medication
MT
2021Health Care Stocks Weaken in Afternoon Trading
MT
2021Novo Nordisk Says Faces Supply Problems With Wegovy Pens in US; Shares Drop
MT
2021Novo Nordisk announces supply challenges for Wegovy® in the US
AQ
2021Novo Nordisk invests more than DKK 17 bn in expansion of the manufacturing facilities i..
AQ
2021Novo Nordisk A/S – Share repurchase programme
AQ
2021Novo Nordisk to Invest More Than $2.68 Billion to Expand Manufacturing Capability in Ka..
MT
2021Novo Nordisk invests $2.6 bln in new production at Danish plant
RE
2021Danish Pharmaceutical Company Novo Nordisk Expands at Home Via $2.6 Billion Investment ..
MT
2021Novo Nordisk Plans $2.6 Billion Investment in Denmark to Boost Manufacturing Capacity
MT
2021NOVO NORDISK : Deutsche Bank reaffirms its Buy rating
MD
2021NOVO NORDISK : Jefferies reiterates its Sell rating
MD
2021European ADRs Move Sharply Lower in Friday Trading
MT
2021Drugmakers cut prices by 62% on average to get China state insurance listing
RE
2021Novo Nordisk A/S – Share repurchase programme
AQ
2021NOVO NORDISK : Deutsche Bank reaffirms its Buy rating
MD
2021Novo Nordisk Secures Canadian Approval for Weight Loss Drug Wegovy
MT
2021NOVO NORDISK : Gets a Neutral rating from UBS
MD
2021NOVO NORDISK : JP Morgan gives a Buy rating
MD
2021NOVO NORDISK : Bernstein remains its Buy rating
MD
2021MASIH YAZDI : EUROPEAN MIDDAY BRIEFING - Stocks, Oil Drop on -2-
DJ
2021Novo Nordisk says lower insulin prices in China dent 2022 outlook
RE
2021Novo Nordisk Projects 3% Decline in 2022 Sales on Lower Insulin Sales in China
MT
2021Novo Nordisk Expects Lower Insulin Prices, Volumes in China to Dent FY22 Global Sales
MT
2021Novo Nordisk announces impact from Volume Based Procurement for insulin in China
AQ
2021Novo Nordisk Announces Health Canada Approves Wegovy? for the Treatment of Adults with ..
CI
2021Alnylam Pharmaceuticals Upgraded to Outperform From Sector Perform by RBC After R&D Day..
MT
2021NOVO NORDISK : Barclays reiterates its Buy rating
MD
2021B. Riley Downgrades Dicerna Pharmaceuticals to Neutral from Buy After Announcing $3.3 B..
MT
2021RBC Downgrades Dicerna Pharmaceuticals to Sector Perform From Outperform, Lifts PT to $..
MT
2021NOVO NORDISK : UBS sticks Neutral
MD
2021Health Care Stocks Ending Little Changed in Quiet Trading
MT
2021Health Care Stocks Weakening This Afternoon
MT
2021NOVO NORDISK : Goldman Sachs remains its Buy rating
MD
2021Dicerna Shares Soar on Takeover by Novo Nordisk
DJ
2021Wall Street Set for Positive Open as Upbeat Nvidia Earnings Buoy Sentiment
MT
2021Health Care Stocks Edge Higher Premarket Thursday
MT
2021Denmark's Novo Nordisk to buy Dicerna Pharma for $3.3 billion
RE
2021Novo Nordisk To Acquire Dicerna Pharmaceuticals
MT
1  2  3  4  5  6  7  8  9  10Next
Upcoming event on NOVO NORDISK A/S
02/02/22